Real‐life treatment of patients with cholinergic urticaria in German‐speaking countries

Abstract

Cholinergic urticaria (CholU) is a frequent type of chronic inducible urticaria. Symptomatic treatment with second‐generation antihistamines (sgAH) is recommended by current guidelines as first‐line therapy, but little is known about how patients with CholU are treated in real life and how they respond to treatment.